TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells.

Abstract:

BACKGROUND:Hypoxia is a common characteristic of solid tumors associated with reduced response to radio- and chemotherapy, therefore increasing the probability of tumor recurrence. The aim of this study was to identify new mechanisms responsible for hypoxia-induced resistance in breast cancer cells. METHODS:MDA-MB-231 and HepG2 cells were incubated in the presence of taxol or etoposide respectively under normoxia and hypoxia and apoptosis was analysed. A whole transcriptome analysis was performed in order to identify genes whose expression profile was correlated with apoptosis. The effect of gene invalidation using siRNA was studied on drug-induced apoptosis. RESULTS:MDA-MB-231 cells incubated in the presence of taxol were protected from apoptosis and cell death by hypoxia. We demonstrated that TMEM45A expression was associated with taxol resistance. TMEM45A expression was increased both in MDA-MB-231 human breast cancer cells and in HepG2 human hepatoma cells in conditions where protection of cells against apoptosis induced by chemotherapeutic agents was observed, i.e. under hypoxia in the presence of taxol or etoposide. Moreover, this resistance was suppressed by siRNA-mediated silencing of TMEM45A. Kaplan Meier curve showed an association between high TMEM45A expression and poor prognostic in breast cancer patients. Finally, TMEM45 is highly expressed in normal differentiated keratinocytes both in vitro and in vivo, suggesting that this protein is involved in epithelial functions. CONCLUSION:Altogether, our results unravel a new mechanism for taxol and etoposide resistance mediated by TMEM45A. High levels of TMEM45A expression in tumors may be indicative of potential resistance to cancer therapy, making TMEM45A an interesting biomarker for resistance.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Flamant L,Roegiers E,Pierre M,Hayez A,Sterpin C,De Backer O,Arnould T,Poumay Y,Michiels C

doi

10.1186/1471-2407-12-391

subject

Has Abstract

pub_date

2012-09-06 00:00:00

pages

391

issn

1471-2407

pii

1471-2407-12-391

journal_volume

12

pub_type

杂志文章
  • A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.

    abstract:BACKGROUND:In Brazil, the rate of cervical cancer remains high despite the availability of screening programs. With ongoing vaccine development and implementation, information on the prevalence of specific HPV types is needed, particularly among high-risk populations, such as HIV-infected women. METHODS:We performed a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1486-4

    authors: Castilho JL,Levi JE,Luz PM,Cambou MC,Vanni T,de Andrade A,Derrico M,Veloso VG,Grinsztejn B,Friedman RK

    更新日期:2015-06-23 00:00:00

  • Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.

    abstract:BACKGROUND:Aprepitant is an FDA-approved medication for chemotherapy-induced nausea and vomiting. It blocks substance P binding to neurokinin-1; substance P has been implicated in itch pathways both as a local and global mediator. CASE PRESENTATIONS:We report a series of four patients, diagnosed with cutaneous T-cell ...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-017-3194-8

    authors: Song JS,Tawa M,Chau NG,Kupper TS,LeBoeuf NR

    更新日期:2017-03-16 00:00:00

  • Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum.

    abstract:BACKGROUND:MicroRNAs (miRs) represent a distinct class of posttranscriptional modulators of gene expression with remarkable stability in sera. Several miRs are oncogenic (oncomiRs) and are deregulated in the pathogenesis of breast cancer and function to inhibit tumor suppressors. Routine blood monitoring of these circu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-448

    authors: Sochor M,Basova P,Pesta M,Dusilkova N,Bartos J,Burda P,Pospisil V,Stopka T

    更新日期:2014-06-18 00:00:00

  • Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma.

    abstract:BACKGROUND:Helicobacter pylori (H. pylori) is thought to have an oncogenic effect on the development of gastric malignancies. However, the effect of H. pylori status on the prognosis of gastric diffuse large B-cell lymphoma (DLBCL) remains unconfirmed. This study aimed to identify the prognostic importance of H. pylori...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6067-5

    authors: Cheng Y,Xiao Y,Zhou R,Liao Y,Zhou J,Ma X

    更新日期:2019-08-28 00:00:00

  • GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment.

    abstract:BACKGROUND:Breast cancer treatment is tailored to the specific cancer subtype. Often, systemic treatment is given prior to surgery. Chemotherapy induces significant endoplasmic reticulum (ER) stress-mediated cell death and upregulation of 78-kDa glucose-regulated protein (GRP78). We hypothesized that chemotherapy induc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06835-z

    authors: Raiter A,Lipovetzki J,Lubin I,Yerushalmi R

    更新日期:2020-04-19 00:00:00

  • Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma.

    abstract:BACKGROUND:High-grade serous ovarian cancer is a detrimental disease. Treatment options in patients with a recurrent disease are dependent on BRCA1/2 mutation status since only patients with known BRCA mutation are eligible for treatment with poly(ADP-ribose) polymerase inhibitors (PARPi). The aim of this study was to ...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/s12885-019-5535-2

    authors: Gornjec A,Novakovic S,Stegel V,Hocevar M,Pohar Marinsek Z,Gazic B,Krajc M,Skof E

    更新日期:2019-04-02 00:00:00

  • Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.

    abstract:BACKGROUND:As one of the malignant tumors most often affecting children and young adults, Ewing sarcoma (ES) is characterized by early metastasis contributing to unfavorable prognosis. However, the molecular mechanisms responsible for ES metastasis remain poorly understood. In this study, we aimed to explore whether Wn...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-480

    authors: Jin Z,Zhao C,Han X,Han Y

    更新日期:2012-10-18 00:00:00

  • Should tumor depth be included in prognostication of soft tissue sarcoma?

    abstract:BACKGROUND:Most staging systems for soft tissue sarcoma are based on histologic malignancy-grade, tumor size and tumor depth. These factors are generally dichotomized, size at 5 cm. We believe it is unlikely that tumor depth per se should influence a tumor's metastatic capability. Therefore we hypothesized that the unf...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-3-17

    authors: Rydholm A,Gustafson P

    更新日期:2003-05-26 00:00:00

  • A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.

    abstract:BACKGROUND:There is an unmet clinical need for better prognostic and diagnostic tools for renal cell carcinoma (RCC). METHODS:Human Protein Atlas data resources, including the transcriptomes and proteomes of normal and malignant human tissues, were searched for RCC-specific proteins and cubilin (CUBN) identified as a ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-3030-6

    authors: Gremel G,Djureinovic D,Niinivirta M,Laird A,Ljungqvist O,Johannesson H,Bergman J,Edqvist PH,Navani S,Khan N,Patil T,Sivertsson Å,Uhlén M,Harrison DJ,Ullenhag GJ,Stewart GD,Pontén F

    更新日期:2017-01-04 00:00:00

  • Angiopoietin-1 deficiency increases tumor metastasis in mice.

    abstract:BACKGROUND:Angipoietin-1 activation of the tyrosine kinase receptor Tek expressed mainly on endothelial cells leads to survival and stabilization of endothelial cells. Studies have shown that Angiopoietin-1 counteracts permeability induced by a number of stimuli. Here, we test the hypothesis that loss of Angiopoietin-1...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3531-y

    authors: Michael IP,Orebrand M,Lima M,Pereira B,Volpert O,Quaggin SE,Jeansson M

    更新日期:2017-08-11 00:00:00

  • Evaluation of the walk-through inflatable colon as a colorectal cancer education tool: results from a pre and post research design.

    abstract:BACKGROUND:Colorectal cancer (CRC) is a disease that can be prevented through early detection. Through the use of effective educational tools, individuals can become better informed about CRC and understand the importance of screening and early detection. The walk through Inflatable Colon is an innovative educational r...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-626

    authors: Sanchez JI,Palacios R,Cole A,O'Connell MA

    更新日期:2014-08-28 00:00:00

  • Testosterone inhibits the growth of prostate cancer xenografts in nude mice.

    abstract:BACKGROUND:Traditional beliefs of androgen's stimulating effects on the growth of prostate cancer (PCa) have been challenged in recent years. Our previous in vitro study indicated that physiological normal levels of androgens inhibited the proliferation of PCa cells. In this in vivo study, the ability of testosterone (...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3569-x

    authors: Song W,Soni V,Soni S,Khera M

    更新日期:2017-09-07 00:00:00

  • Diabetes, glucose control, glucose lowering medications, and cancer risk: a 10-year population-based historical cohort.

    abstract:BACKGROUND:Both diabetes and glucose-lowering medications have been associated with an increased risk of cancer incidence. This study will compare cancer incidence rates in individuals with and without diabetes; and will investigate, in individuals with diabetes, an association between glucose control and cancer incide...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-364

    authors: Dankner R,Balicer R,Boffetta P,Boker LK,Wallenstein S,Freedman L,Goldfracht M,Roth J,Tamler R,LeRoith D

    更新日期:2012-08-23 00:00:00

  • The influence of radiotherapy techniques on the plan quality and on the risk of secondary tumors in patients with pituitary adenoma.

    abstract:BACKGROUND:This planning study compares different radiotherapy techniques for patients with pituitary adenoma, including flatness filter free mode (FFF), concerning plan quality and secondary malignancies for potentially young patients. The flatness filter has been described as main source of photon scatter. MATERIAL ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6535-y

    authors: Treutwein M,Steger F,Loeschel R,Koelbl O,Dobler B

    更新日期:2020-02-03 00:00:00

  • Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma.

    abstract:BACKGROUND:Patients with metastatic renal carcinoma frequently have pre-existing renal impairment and not infrequently develop worsening renal function as a complication of their treatment. The presence of pancreatic metastases in patients with metastatic renal carcinoma, often confers a more favourable prognosis and a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6215-y

    authors: Purshouse K,Chamberlain S,Soares M,Tuthill M,Protheroe A,Mole DR

    更新日期:2019-10-17 00:00:00

  • Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure.

    abstract:BACKGROUND:Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer that is thought to be a precursor to most invasive and metastatic breast cancers. Understanding the mechanisms regulating the invasive transition of DCIS is critical in order to better understand how some types of DCIS become invasive. W...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1007-5

    authors: Bischel LL,Beebe DJ,Sung KE

    更新日期:2015-01-21 00:00:00

  • Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.

    abstract:BACKGROUND:Circulating tumor cells (CTCs) are detectable in peripheral blood of metastatic breast cancer patients (MBC). In this paper we evaluate a new CTC separation method based on a combination of anti-EpCAM- and anti-cytokeratin magnetic cell separation with the aim to improve CTC detection with low target antigen...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-206

    authors: Weissenstein U,Schumann A,Reif M,Link S,Toffol-Schmidt UD,Heusser P

    更新日期:2012-05-30 00:00:00

  • Weight and weight changes throughout life and postmenopausal breast cancer risk: a case-control study in France.

    abstract:BACKGROUND:Overweight and weight gain throughout adult life have been associated with increased risk of breast cancer after the menopause. However the role of body weight at a young age and of the timing of weight gain over the lifetime in postmenopausal breast cancer is not well documented. METHODS:We conducted a pop...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2793-0

    authors: Cordina-Duverger E,Truong T,Anger A,Sanchez M,Arveux P,Kerbrat P,Guénel P

    更新日期:2016-09-29 00:00:00

  • Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report.

    abstract:BACKGROUND:Male breast cancer (MBC) is rare, accounting for only around 1% of all breast cancers. Most MBCs are hormone-driven. Not only the estrogen receptor (ER), but also other steroid hormone receptors, including the androgen receptor (AR) and progesterone receptor (PgR) are expressed in MBC. AR activation in breas...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5216-6

    authors: Takuwa H,Tsuji W,Shintaku M,Yotsumoto F

    更新日期:2018-12-22 00:00:00

  • Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study.

    abstract:BACKGROUND:There are large ethnic differences in cervical cancer survival in New Zealand that are only partly explained by stage at diagnosis. We investigated the association of comorbidity with cervical cancer survival, and whether comorbidity accounted for the previously observed ethnic differences in survival. METH...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-132

    authors: Brewer N,Borman B,Sarfati D,Jeffreys M,Fleming ST,Cheng S,Pearce N

    更新日期:2011-04-12 00:00:00

  • Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review.

    abstract:BACKGROUND:While data from several studies over the last decade has demonstrated that introduction of immunologic checkpoint blockage therapy with anti-CTLA-4/PD-1 drugs leads to improved survival in metastatic melanoma patients, relatively little is known about brain-specific therapeutic response and adverse events in...

    journal_title:BMC cancer

    pub_type: 杂志文章,评审

    doi:10.1186/s12885-018-4470-y

    authors: McDonald MA,Sanghvi P,Bykowski J,Daniels GA

    更新日期:2018-05-09 00:00:00

  • Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer.

    abstract:BACKGROUND:Chemoresistance is one of the main problems in treatment of cancer. Periostin (PN) is a stromal protein which is mostly secreted from cancer associated fibroblasts in the tumor microenvironment and can promote cancer progression including cell survival, metastasis, and chemoresistance. The main objective of ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07761-w

    authors: Oo KK,Kamolhan T,Soni A,Thongchot S,Mitrpant C,O-Charoenrat P,Thuwajit C,Thuwajit P

    更新日期:2021-01-14 00:00:00

  • Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study.

    abstract:BACKGROUND:Evasion of immune surveillance and suppression of the immune system are important hallmarks of tumorigenesis. The goal of this study was to establish distinct patterns that reflect a rectal tumors' immune-phenotype and to determine their relation to patient outcome. METHODS:The study population consisted of...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-486

    authors: Reimers MS,Engels CC,Putter H,Morreau H,Liefers GJ,van de Velde CJ,Kuppen PJ

    更新日期:2014-07-05 00:00:00

  • P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.

    abstract:BACKGROUND:High grade gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) with a Ki67 proliferation index > 20%, include well-differentiated tumours grade 3 (NET G3) and poorly differentiated (PD) neuroendocrine carcinomas (NEC). Abnormal p53-expression is a feature of PD tumours, while expression of chromogran...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6498-z

    authors: Nielsen K,Binderup T,Langer SW,Kjaer A,Knigge P,Grøndahl V,Melchior L,Federspiel B,Knigge U

    更新日期:2020-01-10 00:00:00

  • Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells.

    abstract:BACKGROUND:Aberrant expression and activation of the IGF-IR have been reported in a variety of human cancers and have been associated with resistance to HER targeted therapy. In this study, we investigated the effect of simultaneous targeting of IGF-IR and HER (erbB) family, with NVP-AEW541 and afatinib, on proliferati...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-41

    authors: Ioannou N,Seddon AM,Dalgleish A,Mackintosh D,Modjtahedi H

    更新日期:2013-01-31 00:00:00

  • Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010-2016.

    abstract:BACKGROUND:Oncotype DX® (ODX) is used to assess risk of disease recurrence in hormone receptor positive, HER2-negative breast cancer and to guide decisions regarding adjuvant chemotherapy. Little is known about how physician factors impact treatment decisions. The purpose of this study was to examine patient and physic...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07355-6

    authors: Schwedhelm TM,Rees JR,Onega T,Zipkin RJ,Schaefer A,Celaya MO,Moen EL

    更新日期:2020-09-03 00:00:00

  • Design of the study: how can health care help female breast cancer patients reduce their stress symptoms? A randomized intervention study with stepped-care.

    abstract:BACKGROUND:A life threatening illness such as breast cancer can lead to a secondary diagnosis of PTSD (post traumatic stress disorder) with intrusive thoughts and avoidance as major symptoms. In a former study by the research group, 80% of the patients with breast cancer reported a high level of stress symptoms close t...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/1471-2407-12-167

    authors: Nordin K,Rissanen R,Ahlgren J,Burell G,Fjällskog ML,Börjesson S,Arving C

    更新日期:2012-05-04 00:00:00

  • MiR-200c and HuR in ovarian cancer.

    abstract:BACKGROUND:MicroRNAs in solid malignancies can behave as predictors of either good or poor outcome. This is the case with members of the miR-200 family, which are the primary regulators of the epithelial to mesenchymal transition and have been reported to act as both oncogenes and tumor suppressors. This study assessed...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-72

    authors: Prislei S,Martinelli E,Mariani M,Raspaglio G,Sieber S,Ferrandina G,Shahabi S,Scambia G,Ferlini C

    更新日期:2013-02-08 00:00:00

  • Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology.

    abstract:BACKGROUND:Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) usually presents in middle aged men and shows an indolent clinical behavior. However, up to 30% of the patients present a secondary transformation into aggressive diffuse large B cell lymphoma (DLBCL). The aim of the present study was to characterize mo...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-332

    authors: Hartmann S,Eray M,Döring C,Lehtinen T,Brunnberg U,Kujala P,Vornanen M,Hansmann ML

    更新日期:2014-05-13 00:00:00

  • Extragenital Müllerian adenosarcoma with pouch of Douglas location.

    abstract:BACKGROUND:Of all female genital tract tumors, 1-3% are stromal malignancies. In 8-10% of cases, these are represented by Müllerian adenosarcoma an extremely rare tumor characterized by a stromal component of usually low-grade malignancy and by a benign glandular epithelial component. Variant that arises in the pouch o...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-171

    authors: Patrelli TS,Silini EM,Gizzo S,Berretta R,Franchi L,Thai E,Lukanovic A,Nardelli GB,Modena AB

    更新日期:2011-05-15 00:00:00